Enhancing Vaccination Uptake Through Points Redemption Based Financial Incentives and Digital Platforms: an Open-label Cluster Randomized Controlled Trial Utilizing Community Mobilization and Empowerment Strategies
Launched by BO YAN · Mar 20, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying ways to encourage more people in China to get vaccinated, especially for vaccines that are not part of the usual government vaccination program, like HPV and flu vaccines. The researchers are developing a digital platform that rewards people with points when they get vaccinated or engage in other healthy behaviors. These points can be redeemed for gifts or discounts on health services. The goal is to see if this system can increase the number of people getting these important vaccines and improve their overall health habits.
To participate, you need to be living in a specific area for at least a year, be able to understand and agree to the study, and not have any mental health issues that would prevent you from following the study's requirements. You will use a simple digital app where you can log your health behaviors, and after getting vaccinated, you'll scan a QR code at your local health center to earn points. This trial is not yet recruiting participants, but it aims to create a cost-effective and easy-to-replicate way to boost vaccination rates in the community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Do not move from the original research and implementation site within the next year;
- • Voluntarily participate in the study and sign the informed consent;
- • No mental disorder or cognitive impairment, able to understand and cooperate with research requirements.
- Exclusion Criteria:
- • Have contraindications related to vaccination;
- • The state of the body during the intervention period is not suitable for vaccination.
About Bo Yan
Bo Yan is a pioneering clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative therapies. With a strong emphasis on scientific integrity and ethical standards, Bo Yan collaborates with leading research institutions and healthcare professionals to conduct rigorous clinical trials across various therapeutic areas. Committed to transparency and patient safety, the organization leverages cutting-edge technologies and methodologies to accelerate the development of effective treatments while ensuring compliance with regulatory guidelines. Bo Yan aims to contribute significantly to the global healthcare landscape by fostering collaboration and driving breakthroughs in medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported